Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD - a Randomized, Double-blind, Non-inferiority Study (The "RECUT"-Trial)

NCT02386735 is registered in ClinicalTrials.gov with Prof. Dr. Jörg Leuppi as lead sponsor.

NCT NCT02386735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02386735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD - a Randomized, Double-blind, Non-inferiority Study (The "RECUT"-Trial)
Lead sponsor
Prof. Dr. Jörg Leuppi
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2015
Completion date
July 31, 2024
Enrollment
133 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse effect of glucocorticoids and synthetic analogues, disease exacerbation, pulmonary disease, chronic obstructive